- Business Wire•8 months ago
Celgene Corporation today announced it has received a Paragraph IV Notice Letter advising that Actavis LLC submitted an Abbreviated New Drug Application to the U.S.
We're sorry this is all we were able to find about this topic.
Celgene Corporation - Contingen (CELGZ)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52wk Range||undefined - undefined|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|